← All trials
NCT01898182
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 30, 2013
- Primary completion
- Jul 31, 2014
- Completion date
- Sep 30, 2014
- First posted
- Jul 12, 2013
- Last posted
- Sep 15, 2014
- Enrollment
- 132
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Makati Medical CenterLead sponsor
- Makati Medical CenterOverall official - principal investigator
- Makati Medical CenterReponsible party - principal investigator
- Makati Medical CenterSponsor investigator
- Makati Medical CenterOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.